News
Scientists at UC San Francisco have discovered how pancreatic cancer cells thrive in the lungs or liver, environments that ...
Cell-free DNA-based liquid biopsies showed promise for monitoring response to pancreatic cancer therapies and making ...
Novocure (Nasdaq:NVCR) today announced positive results from the Phase 3 PANOVA-3 trial of its tumor-treating fields (TTFields) therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results